The food and drug administration's (FDA) center for drug evaluation & research (CDER), office of management (OM), immediate office (IO), is seeking the services of an executive assistant I to fill a…
Ended Awarded Last action
- Contract number
- 75F40120F19104
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $52,745
Award facts
- Contract value 54% obligated
-
- $52,744.80 Current, with exercised options
- $98,490.24 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$3,000 | |
| Supplemental Agreement for work within scope | $9,999 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $45,745 |
About this award
This is a $98,490.24 Blanket Purchase Agreement (BPA) call issued by the Food and Drug Administration's (FDA) Center for Drug Evaluation & Research (CDER), Office of Management (OM), Immediate Office (IO) to acquire the services of an Executive Assistant I on a temporary, critical need basis. The BPA is under the Professional Services Schedule (PSS) contract vehicle. The prime contractor is Brillient Corporation, a minority-owned, for-profit Subchapter S Corporation that provides a range of professional and technical services to federal agencies. There is no set-aside designation for this award.
Description
The food and drug administration's (FDA) center for drug evaluation & research (CDER), office of management (OM), immediate office (IO), is seeking the services of an executive assistant I to fill a temporary critical need.
Quick answers
Who was awarded contract 75F40120F19104?
75F40120F19104 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on February 5, 2020.
How much is contract 75F40120F19104 worth?
The government has obligated $52,745 on 75F40120F19104. Its potential value, with all options, is $98,490.
Is contract 75F40120F19104 an order under another contract?
Yes. 75F40120F19104 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75F40120F19104 competed?
The extent of competition for 75F40120F19104 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award